Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
INFIMEDIC from Hélécine, company number BE0474901211, closed financial year 2025 with a result of € 6,024 after tax. For that financial year INFIMEDIC recorded a gross margin of € 123,849 and equity of € 73,343. Compared with financial year 2024, the result moved from € 19,305 to € 6,024. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 73,343
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6,024
▼ 69% vs 2024
Profit after tax over the fiscal year.
€ 60,295
▲ 13% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
€ 109,674
▲ 24% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 16,031
▲ 52% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,880
▲ 154% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 128,609 | € 108,598 | € 119,883 | € 123,849 | ▲ 3% |
| Profit after taxes | € 4,690 | € -22,756 | € 19,305 | € 6,024 | ▼ 69% |
| Equity | € 70,770 | € 48,014 | € 67,319 | € 73,343 | ▲ 9% |
| Total debts | € 5,779 | € 3,105 | € 2,935 | € 3,880 | ▲ 32% |
| Cash | € 46,103 | € 28,918 | € 53,154 | € 60,295 | ▲ 13% |
| Retained profit | € 70,770 | € 48,014 | € 67,319 | € 73,343 | ▲ 9% |
| Balance sheet total | € 76,549 | € 51,119 | € 70,254 | € 77,223 | ▲ 10% |
Key figures of INFIMEDIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INFIMEDIC?
What happened at INFIMEDIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 6,024 (▼ 69% vs 2024). Source: NBB ↗
- New establishment in Hélécine. KBO
- Start of the company according to the CBE. KBO
In short
From € 4,690 profit in 2022 to € 6,024 profit in 2025.
Paid € 1,480 in corporate taxes since 2022.
Best year ever: 2024, with € 19,305 profit.
Management
Behind INFIMEDIC are Sandrine DARQUENNE, Zoé MYAUX and Carine HEIRBAUT.
Directors
According to the 2025 annual accounts
Sandrine DARQUENNE
Director
Zoé MYAUX
Director
Carine HEIRBAUT
Director
Establishments
Establishment units
Physical locations of this company
Rue du Tuffeau 3
1357 Hélécine
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
INFOMANIAK-AS, CH
Website info
Features
Security
Network
Details
- Company number
- 0474.901.211
- VAT number
- BE 0474.901.211
- Registered office
- Rue du Tuffeau 3, 1357 Hélécine
- Names & denominations
- INFIMEDIC
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 13 April 2001
- Peppol
- Not registered
- Contact
- infimedic.be
- Activities · NACE
Activiteiten van verpleegkundigen en verloskundigen
Verpleegkundige activiteiten